Sorafenib-induced pancreatitis

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Journal of Experimental and Clinical Medicine
Volume:32 Issue:3
Sorafenib-induced pancreatitis

Sorafenib-induced pancreatitis

Authors : Talat AYYILDIZ, Taner AYDIN, Ahmet Tarık EMİNLER, Çınar YILDIRIM, Kader IRAK, Murat KIYICI, Selim GÜREL, Selim Giray NAK, Macit GÜLTEN, Enver DOLAR

Pages : 133-135

View : 43 | Download : 11

Publication Date : 2015-11-17

Article Type : Research Paper

Abstract :Sorafenib is an inhibitor of multikinase proteins which is used for metastatic renal cell carcinoma and advanced stage hepatocellular carcinoma. Its side effects include serum amylase and lipase elevations anticipated to occur within first weeks of treatment but clinically and radiologically evident acute pancreatitis develops rarely. Five cases of acute pancreatitis have been reported in literature until date. The case we described here is the sixth case of clinically diagnosed acute pancreatitis.
Keywords : Hepatocellular carcinoma, Pancreatitis, Sorafenib, Tyrosine kinase inhibitor

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.